This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: cancer-related-medication-request-gefitinib - XML Representation

Raw xml | Download

<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="cancer-related-medication-request-gefitinib"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="cancer-related-medication-request-gefitinib"> </a><a name="hccancer-related-medication-request-gefitinib"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;cancer-related-medication-request-gefitinib&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#373808002)</span></p><p><b>Normalization Basis Extension</b>: Body surface area (observable entity) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#301898006)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: gefitinib 250 MG Oral Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#349472)</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-john-anyperson.html">Patient/cancer-patient-john-anyperson</a> &quot; ANYPERSON&quot;</p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-kyle-anydoc.html">Practitioner/us-core-practitioner-kyle-anydoc</a> &quot; ANYDOC&quot;</p><p><b>reasonCode</b>: Non-small cell lung cancer (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#254637007)</span></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: 250mg orally once daily with or without food</p><p><b>timing</b>: Code: QD, Events: 2019-04-01, Starting 2019-04-30, Once per 1 days</p><p><b>route</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>
  </text>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="373808002"/>
        <display value="Curative - procedure intent"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="301898006"/>
        <display value="Body surface area (observable entity)"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <status value="active"/>
  <intent value="order"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="349472"/>
      <display value="gefitinib 250 MG Oral Tablet"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/cancer-patient-john-anyperson"/>
  </subject>
  <authoredOn value="2019-04-01"/>
  <requester>🔗 
    <reference value="Practitioner/us-core-practitioner-kyle-anydoc"/>
  </requester>
  <reasonCode>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="254637007"/>
      <display value="Non-small cell lung cancer (disorder)"/>
    </coding>
  </reasonCode>
  <dosageInstruction>
    <text value="250mg orally once daily with or without food"/>
    <timing>
      <event value="2019-04-01"/>
      <repeat>
        <boundsPeriod>
          <start value="2019-04-30"/>
        </boundsPeriod>
        <frequency value="1"/>
        <period value="1"/>
        <periodUnit value="d"/>
      </repeat>
      <code>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/v3-GTSAbbreviation"/>
          <code value="QD"/>
        </coding>
      </code>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="26643006"/>
        <display value="Oral use"/>
      </coding>
    </route>
    <doseAndRate>
      <doseQuantity>
        <value value="250"/>
        <unit value="mg"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg"/>
      </doseQuantity>
    </doseAndRate>
  </dosageInstruction>
</MedicationRequest>